These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27021326)

  • 41. Identification of fusidic acid resistance in clinical isolates of Staphylococcus pseudintermedius from dogs in Korea.
    Lim YJ; Hyun JE; Hwang CY
    Vet Dermatol; 2020 Aug; 31(4):267-e62. PubMed ID: 32115810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of global patterns and the genetics of fusidic acid resistance.
    Farrell DJ; Castanheira M; Chopra I
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S487-92. PubMed ID: 21546625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low prevalence of mupirocin resistance in Belgian Staphylococcus aureus isolates collected during a 10 year nationwide surveillance.
    Nagant C; Deplano A; Nonhoff C; De Mendonça R; Roisin S; Dodémont M; Denis O
    J Antimicrob Chemother; 2016 Jan; 71(1):266-7. PubMed ID: 26377863
    [No Abstract]   [Full Text] [Related]  

  • 44. [Outburst of fusidic acid resistant Staphylococcus aureus].
    Kanazaki H; Akiyama H; Kanamoto A; Abe Y; Yamada T; Arata J; Umemura S; Ikeda M
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):507-10. PubMed ID: 2614994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
    Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of fusB-mediated fusidic acid resistance islands in Staphylococcus epidermidis isolates.
    Chen HJ; Tsai JC; Hung WC; Tseng SP; Hsueh PR; Teng LJ
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5842-9. PubMed ID: 21968364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid.
    Tünger O; Arisoy A; Kurutepe S; Akçali S; Ozbakkaloğlu B
    Int J Antimicrob Agents; 2001 Nov; 18(5):445-7. PubMed ID: 11711260
    [No Abstract]   [Full Text] [Related]  

  • 48. Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101.
    O'Brien FG; Price C; Grubb WB; Gustafson JE
    J Antimicrob Chemother; 2002 Sep; 50(3):313-21. PubMed ID: 12205055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus.
    O'Neill AJ; Chopra I
    Mol Microbiol; 2006 Jan; 59(2):664-76. PubMed ID: 16390458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?
    Klein S; Nurjadi D; Eigenbrod T; Bode KA
    Int J Antimicrob Agents; 2016 Feb; 47(2):155-7. PubMed ID: 26774158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013.
    Souli M; Karaiskos I; Galani L; Maraki S; Perivolioti E; Argyropoulou A; Charissiadou A; Zachariadou L; Tsiplakou S; Papaioannou V; Tsorlini H; Katsifa H; Baka V; Pantazi P; Paschali A; Kyratsa A; Trikka-Graphakos E; Giannopoulou P; Vogiatzakis E; Moraitou H; Papadogeorgaki H; Avgerinou H; Panagea T; Pantazatou A; Petinaki E; Stamatopoulou G; Toutouza M; Karatzoglou I; Kontopoulou K; Orfanidou M; Karantani I; Fytas P; Tzanetou K; Platsouka E; Kazila P; Chli A; Statiri N; Giamarellou H
    Infect Dis (Lond); 2016 Apr; 48(4):287-292. PubMed ID: 26635179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
    Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mupirocin resistance in Staphylococcus aureus in an Indian hospital.
    Gadepalli R; Dhawan B; Mohanty S; Kapil A; Das BK; Chaudhry R; Samantaray JC
    Diagn Microbiol Infect Dis; 2007 May; 58(1):125-7. PubMed ID: 17240103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
    El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
    J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fusidic acid resistance in Staphylococcus aureus isolates.
    Brown EM; Thomas P
    Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
    [No Abstract]   [Full Text] [Related]  

  • 56. Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate.
    Price CTD; Gustafson JE
    J Med Microbiol; 2001 Jan; 50(1):104-106. PubMed ID: 11192496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efforts to support the development of fusidic acid in the United States.
    Fernandes P; Pereira D
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S542-6. PubMed ID: 21546632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Antimicrob Chemother; 2015 Jul; 70(7):2053-6. PubMed ID: 25814163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical Staphylococcus aureus strains].
    Nakipoğlu Y; Iğnak S; Gürler N; Gürler B
    Mikrobiyol Bul; 2012 Apr; 46(2):180-9. PubMed ID: 22639307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
    Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
    J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.